A Study to Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®)

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

May 4, 2018

Primary Completion Date

September 14, 2020

Study Completion Date

September 14, 2020

Conditions
Polyarticular Juvenile Arthritis
Trial Locations (14)

119049

Morozovskaya Children's City Clinical Hospital /ID# 207006, Moscow

119992

Sechenov First Moscow Medical /ID# 207005, Moscow

141009

"State Budgetary Healthcare Institution Moscow Region Moscow Regional Consultati /ID# 212874", Mytischi

194100

Saint Petersburg State Pediatric Medical University /ID# 203169, Saint Petersburg

410012

Saratov State Medical University n.a. V.I. Razumovskiy /ID# 206319, Saratov

420012

Kazan State Medical Academy /ID# 207004, Kazan'

430005

Federal State Budgetary Educational Institution of Higher Education National Re /ID# 212361, Saransk

443070

Samara Regional Clinical Cardiology Clinic /ID# 206120, Samara

450106

Republican Children's Clinical Hospital /ID# 204830, Ufa

454087

Chelyabinsk Regional Children's Clinical Hospital /ID# 204829, Chelyabinsk

460006

Regional Children's Clinical Hospital /ID# 206121, Orenburg

603136

GBUZ NO Regional Children's Clinical Hospital /ID# 212362, Nizhny Novgorod

603155

Privolzhsky Federal Medical Research Center /ID# 206318, Nizhny Novgorod

620149

"State Budgetary Health Institution Regional Children's Clinical Hospital №1 /ID# 212363", Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY